Coloplast
874
DKK
-0.79 %
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
5 following
-0.79%
-0.64%
-2.5%
-1.55%
+2.82%
+13.21%
+16.19%
-25.55%
+8.33%
+1,763.54%
investor.coloplast.com/investor-relations
Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Revenue
27.03B
EBIT %
27.08 %
P/E
38.91
Dividend yield-%
2.52 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
COLO B
Daily low / high price
870.4 / 877.6
DKK
Market cap
199.45B DKK
Turnover
25.58M DKK
Volume
29K
Financial calendar
General meeting
05.12.2024
Half year dividend
06.12.2024
Interim report
04.02.2025
Interim report
06.04.2025
Interim report
19.08.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Niels Peter Louis-Hansen | 20.7 % | 41.1 % |
Aage og Johanne Louis-Hansens Fond | 11.5 % | 15.2 % |
Benedicte Fund | 3.7 % | 5.4 % |
ShowingAll content types
Coloplast A/S - Notice of Annual General Meeting 2024
Coloplast A/S - Indkaldelse til ordinær generalforsamling 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools